Glenmark Pharma to spin off generics unit, list new unit next year

17 Nov 2007

1

Mumbai: Glenmark Pharmaceuticals Ltd plans to spin off its generics business into a new subsidiary and list it through an initial public offer by middle of next year, a senior company official said.

The company plans to dilute not more than 30 per cent of the new subsidiary, Glenmark Generics Ltd, Glenn Saldanha, managing director, said at a press conference.

The funds raised from the IPO would be used to acquire a marketing firm in the US, build the parent''s speciality drug business and build a late state research pipeline, he added.

The generics business had revenues of $90 million in the financial year to March 2007, while the speciality drug business generated $197 million revenue, he said.

Saldanha said in the current financial year, the generics business is expected to double to $180 million and speciality drug would have $306 million revenue.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more